Use of 2-(purin-9-yl)-tetrahydofuran-3,4-diol derivatives as adenosine A2A receptor agonists

Details for Australian Patent Application No. 2007241341 (hide)

Owner Novartis AG

Inventors Taylor, Roger John; Fairhurst, Robin Alec

Agent Davies Collison Cave

Pub. Number AU-A-2007241341

PCT Pub. Number WO2007/121918

Priority 0607951.1 21.04.06 GB

Filing date 19 April 2007

Wipo publication date 1 November 2007

International Classifications

A61K 31/52 (2006.01)

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07D 473/16 (2006.01) Heterocyclic compounds containing purine ring systems

C07H 19/167 (2006.01) Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

Event Publications

16 October 2008 PCT application entered the National Phase

  PCT publication WO2007/121918 Priority application(s): WO2007/121918

7 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007241342-Purine derivatives with activity to the adenosine A2A receptor

2007241340-Purine derivatives as adenosine receptor activator